GPT and metabolic dysfunction-associated steatotic liver disease: Third, our outcomes (glucose, triglycerides, cholesterol, HDL-cholesterol, LDL-cholesterol, alanine transaminase, gamma-glutamyl-transferase and uric acid) were chosen because we considered them the most relevant biomarkers associated to metabolic syndrome and NAFLD.